Cita NeuroPharmaceutical Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $65M

Cita NeuroPharmaceutical General Information

Description

Developer of small molecule drug candidates for neurological diseases and disorders. The company is a neuropharmaceutical company focused on the development and commercialization of small molecule drug candidates for neurological diseases and disorders.

Contact Information

Formerly Known As
GB Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2480 Dunwin Drive
  • Mississauga, Ontario L5L 1J9
  • Canada
+1 (905)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 2480 Dunwin Drive
  • Mississauga, Ontario L5L 1J9
  • Canada
+1 (905)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cita NeuroPharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 18-Nov-2005 $65M Completed Product Development
1. Early Stage VC 01-Jan-2002 Completed Product Development
To view Cita NeuroPharmaceutical’s complete valuation and funding history, request access »

Cita NeuroPharmaceutical Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
GrowthWorks Venture Capital Minority
MMV Capital Partners Growth/Expansion Minority
MedInnova Partners Venture Capital Minority
To view Cita NeuroPharmaceutical’s complete investors history, request access »

Cita NeuroPharmaceutical FAQs

  • When was Cita NeuroPharmaceutical founded?

    Cita NeuroPharmaceutical was founded in 1997.

  • Where is Cita NeuroPharmaceutical headquartered?

    Cita NeuroPharmaceutical is headquartered in Mississauga, Canada.

  • What industry is Cita NeuroPharmaceutical in?

    Cita NeuroPharmaceutical’s primary industry is Biotechnology.

  • Is Cita NeuroPharmaceutical a private or public company?

    Cita NeuroPharmaceutical is a Private company.

  • What is the current valuation of Cita NeuroPharmaceutical?

    The current valuation of Cita NeuroPharmaceutical is .

  • What is Cita NeuroPharmaceutical’s current revenue?

    The current revenue for Cita NeuroPharmaceutical is .

  • Who are Cita NeuroPharmaceutical’s investors?

    GrowthWorks, MMV Capital Partners, and MedInnova Partners have invested in Cita NeuroPharmaceutical.

  • When was Cita NeuroPharmaceutical acquired?

    Cita NeuroPharmaceutical was acquired on 18-Nov-2005.

  • Who acquired Cita NeuroPharmaceutical?

    Cita NeuroPharmaceutical was acquired by Vernalis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process